EUVIMEDEUVIMED entdecken
Crossref

Asymmetrical branched PEG-modified liposomes evade anti-PEG antibody recognition to abolish accelerated blood clearance and amplify tumor drug accumulation

Kunfeng Zhang, Mingze Li, Dezhi Sui, Jingyi Zhao, Zhennan She, Kaihe Ding, Xiaoqiu Shang, Zhouchunxiao Du, Ning Wang, Yuanyuan Lu, Yanzhi Song, Yihui Deng

Nanoscale · 2025 · 17 (37) · 21693-21705

DOI: 10.1039/d5nr01680k ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Kunfeng Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road, No. 103, Shenyang 110016, China. songyanzhi@syphu.edu.cn. Hauptthemen laut MEDLINE: Polyethylene Glycols, Liposomes, Antibodies, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of anti-polyethylene glycol (PEG) antibodies poses a significant challenge for the clinical translation of PEGylated liposomes, leading to an accelerated blood clearance (ABC) phenomenon and diminishing therapeutic effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyethylene GlycolsLiposomesAntibodiesAntineoplastic AgentsAnimalsMiceCell Line, TumorHumansProdrugsCarbocyaninesPhosphatidylethanolamines

Substanzen

Polyethylene GlycolsLiposomesAntibodiesAntineoplastic AgentsProdrugsCarbocyaninesPhosphatidylethanolamines

Autor:innen und Institutionen

  • College of Pharmacy, Shenyang Pharmaceutical University, Wenhua Road, No. 103, Shenyang 110016, China. songyanzhi@syphu.edu.cn.
  • School of Pharmaceutical Science & Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, K., Li, M., Sui, D., Zhao, J., She, Z., Ding, K., Shang, X., Du, Z., Wang, N., Lu, Y., Song, Y., & Deng, Y. (2025). Asymmetrical branched PEG-modified liposomes evade anti-PEG antibody recognition to abolish accelerated blood clearance and amplify tumor drug accumulation. Nanoscale, 17(37), 21693-21705. https://doi.org/10.1039/d5nr01680k

Vancouver

Zhang K, Li M, Sui D, Zhao J, She Z, Ding K, et al. Asymmetrical branched PEG-modified liposomes evade anti-PEG antibody recognition to abolish accelerated blood clearance and amplify tumor drug accumulation. Nanoscale. 2025;17(37):21693-21705. doi:10.1039/d5nr01680k

BibTeX
@article{Zhang2025,
  author = {Zhang, Kunfeng and Li, Mingze and Sui, Dezhi and Zhao, Jingyi and She, Zhennan and Ding, Kaihe and Shang, Xiaoqiu and Du, Zhouchunxiao and Wang, Ning and Lu, Yuanyuan and Song, Yanzhi and Deng, Yihui},
  title = {Asymmetrical branched PEG-modified liposomes evade anti-PEG antibody recognition to abolish accelerated blood clearance and amplify tumor drug accumulation},
  journal = {Nanoscale},
  year = {2025},
  volume = {17},
  number = {37},
  pages = {21693--21705},
  doi = {10.1039/d5nr01680k}
}
Kostenlos starten →